Pharmacies halt OTC sales and ration Aspirin as cost price rockets

Pharmacies are experiencing “widespread shortages” of Aspirin and 86% were unable to supply Aspirin to patients last week, according to a poll by the National Pharmacy Association (NPA).

Aspirin
• Source: Shutterstock

Pharmacies are “tightly rationing” supplies of Aspirin for patients, a snap poll of 540 pharmacies last week by the NPA has found.

It said pharmacists had reported restricting Aspirin to patients with “acute heart conditions” or for “emergency prescriptions”.

It also said a “number” have also said they have stopped making aspirin available for over-the-counter sales.

Read more: Government bans aspirin exports as shortages hit pharmacies

The price of aspirin has “soared” in the last eight weeks, the NPA said its pricing analysis had found.

Highlighting an example, it said the price per pack of Aspirin 75mg dispersible tablets had increased to £3.90 this month, but the NHS will reimburse pharmacies £2.18 a packet, meaning an average pharmacy will lose £1.72 each time it is dispensed.

Read more: Creon cancer drug SSPs extended for third time into new year

“We’re concerned,” said NPA chair Olivier Picard. “For pharmacies that can get hold of supply, costs will far exceed what they will be reimbursed by the NHS, yet more signs of a fundamentally broken pharmacy contract in desperate need of reform by the government.

“We’ve long called for pharmacists to be able to make substitutions where a medicine is not in stock,” he added.

“The status quo is not only frustrating for patients, it is also dangerous.

“It is madness to send someone back to their GP to get a prescription changed when a safe alternative is in stock.”

Read more: DH launches consultation on substitutions

Aspirin is commonly used to treat patients with a history of strokes, heart disease, chronic kidney disease and diabetes.

Fifty million prescriptions for Aspirin were dispensed in the UK in 2025.

The NPA also called on the government to “reform the broken pharmacy contract” which “regularly leaves pharmacists dispensing NHS prescriptions at a loss”.

Negotiations for the upcoming CPCF contract are set to begin soon.

James Halliwell

Read more by James Halliwell

James Halliwell joined C+D as editor-in-chief in February 2024. A business journalist for the last 15 years, he’s looking forward to developing the bond between C+D and its readers and bringing them more of what they want to read, in the evolving ways they want to read it.

Latest from News

More from